News - MedTech & Diagnostics
B. Braun launches renal care centres in NSW and QLD

MedTech News: B. Braun, one of the world’s leading providers of medical devices, dialysis products and renal care services has opened two new haemodialysis centres.
The new facilities located in New South Wales and Queensland are the latest additions to over 350 B. Braun renal care clinics caring for almost 30,000 patients around the world.
The first new renal care centre in Gregory Hills, New South Wales, will allow B. Braun to provide quality renal care to Campbelltown community. Located in close proximity to the Campbelltown Public Hospital, will have capacity to provide for up to 64 patients with haemodialysis treatment per week over two shifts.
The second new haemodialysis unit in Morayfield, Queensland, located 46 km north of Brisbane is part of the Morayfield Health Hub. The new facility will support patients and the renal care needs of the local community. The Morayfield facility will have capacity to provide clinical care for up to 68 patient per week over two shifts.
Russ Hoskins, Division Head of Renal Care Centres, B. Braun Australia, said “With more than 40 years of experience in haemodialysis treatment, B. Braun is strongly committed to providing high quality renal care close to our patients. Our topmost priority remains always the well-being of our customers. We want to make sure that everyone who is in our care, feels comfortable and receives life-enriching healthcare through clinical excellence and evidence based practice.”
Both the facilities are equipped with the latest dialysis machine technology – the Dialog iQ. The new system is designed with two inputs to give improved information on the patient’s hemodynamic condition. Dialog iQ’s system intelligence is able to extrapolate data from multiple information sources and take the appropriate action based on the patient’s individual needs.
Back in 2018, B. Braun also acquired Diaverum renal care centres in Australia and New Zealand to expand their footprint.
Leadership & Management
David Henderson appointed Takeda Oceania Country Head
David Henderson has been appointed Country Head for Takeda Oceania, succeeding Dave Pearce, as the pharmaceutical company continues to reshape […]
MoreNews - Pharmaceuticals
GBMA puts medicine shortages on the table as strategic agreement talks begin
As the Generic and Biosimilar Medicines Association (GBMA) begins negotiations with government on the next strategic agreement, it has unveiled […]
MoreNews - MedTech & Diagnostics
Australia sets a new course for prostate cancer detection
Australia has become one of the first countries in the world to adopt a modern, evidence-based framework for the early […]
MoreNews - Pharmaceuticals
IVF success rates climb as ART sector faces major accreditation overhaul
Australians undergoing in vitro fertilisation (IVF) are now more likely to take home a baby than they were five years […]
More